| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:49 UTC |
|---|
| Update Date | 2022-03-07 02:51:39 UTC |
|---|
| HMDB ID | HMDB0014539 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Carisoprodol |
|---|
| Description | Carisoprodol, also known as soma or isoprotane, belongs to the class of organic compounds known as carbamate esters. Carbamate esters are compounds containing an ester of carbamic acid with the general structure R2NC(=O)OR' (R' not H). They are esters of carbamic acids. Based on a literature review a small amount of articles have been published on Carisoprodol. |
|---|
| Structure | CCCC(C)(COC(N)=O)COC(=O)NC(C)C InChI=1S/C12H24N2O4/c1-5-6-12(4,7-17-10(13)15)8-18-11(16)14-9(2)3/h9H,5-8H2,1-4H3,(H2,13,15)(H,14,16) |
|---|
| Synonyms | | Value | Source |
|---|
| (+-)-2-Methyl-2-propyl-1,3-propanediol carbamate isopropylcarbamate | ChEBI | | (1-Methylethyl)carbamic acid 2-(((aminocarbonyl)oxy)methyl)-2-methylpentyl ester | ChEBI | | 2-Methyl-2-propyl-1,3-propanediol carbamate isopropylcarbamate | ChEBI | | 2-Methyl-2-propyltrimethylene carbamate isopropylcarbamate | ChEBI | | Carbamic acid 2-isopropylcarbamoyloxymethyl-2-methyl-pentyl ester | ChEBI | | Carisoprodolum | ChEBI | | Isopropyl meprobamate | ChEBI | | N-Isopropy-2-methyl-2-propyl-1,3-propanediol dicarbamate | ChEBI | | Soma | Kegg | | (+-)-2-Methyl-2-propyl-1,3-propanediol carbamic acid isopropylcarbamic acid | Generator | | (1-Methylethyl)carbamate 2-(((aminocarbonyl)oxy)methyl)-2-methylpentyl ester | Generator | | 2-Methyl-2-propyl-1,3-propanediol carbamic acid isopropylcarbamic acid | Generator | | 2-Methyl-2-propyltrimethylene carbamic acid isopropylcarbamic acid | Generator | | Carbamate 2-isopropylcarbamoyloxymethyl-2-methyl-pentyl ester | Generator | | Isopropyl meprobamic acid | Generator | | N-Isopropy-2-methyl-2-propyl-1,3-propanediol dicarbamic acid | Generator | | Carisoprodate | HMDB | | Carisoprodatum | HMDB | | Isomeprobamate | HMDB | | Isoprotane | HMDB | | Isoprothane | HMDB | | Isopropylmeprobamate | HMDB | | Mio relax | HMDB | | Schein brand OF carisoprodol | HMDB | | Somalgit | HMDB | | Soprodol | HMDB | | Vanadom | HMDB | | Wallace brand 1 OF carisoprodol | HMDB | | Belmac brand OF carisoprodol | HMDB | | Carisoma | HMDB | | Forest brand OF carisoprodol | HMDB | | GM Pharmaceuticals brand OF carisoprodol | HMDB | | Isobamate | HMDB | | Carter horner brand OF carisoprodol | HMDB | | Wallace brand 2 OF carisoprodol | HMDB | | Wallace brand 3 OF carisoprodol | HMDB |
|
|---|
| Chemical Formula | C12H24N2O4 |
|---|
| Average Molecular Weight | 260.33 |
|---|
| Monoisotopic Molecular Weight | 260.173607266 |
|---|
| IUPAC Name | 2-[(carbamoyloxy)methyl]-2-methylpentyl N-(propan-2-yl)carbamate |
|---|
| Traditional Name | Soma |
|---|
| CAS Registry Number | 78-44-4 |
|---|
| SMILES | CCCC(C)(COC(N)=O)COC(=O)NC(C)C |
|---|
| InChI Identifier | InChI=1S/C12H24N2O4/c1-5-6-12(4,7-17-10(13)15)8-18-11(16)14-9(2)3/h9H,5-8H2,1-4H3,(H2,13,15)(H,14,16) |
|---|
| InChI Key | OFZCIYFFPZCNJE-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as carbamate esters. Carbamate esters are compounds containing an ester of carbamic acid with the general structure R2NC(=O)OR' (R' not H). They are esters of carbamic acids. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Carbamate esters |
|---|
| Alternative Parents | |
|---|
| Substituents | - Carbamic acid ester
- Carbonic acid derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 92 - 93 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.79 g/L | Not Available | | LogP | 2.1 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.83 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 11.3867 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 0.81 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 38.9 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1698.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 231.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 135.1 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 152.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 89.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 354.9 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 417.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 114.0 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 888.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 379.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1097.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 241.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 289.2 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 276.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 218.4 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 17.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Carisoprodol,1TMS,isomer #1 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N[Si](C)(C)C | 1990.9 | Semi standard non polar | 33892256 | | Carisoprodol,1TMS,isomer #1 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N[Si](C)(C)C | 1956.5 | Standard non polar | 33892256 | | Carisoprodol,1TMS,isomer #1 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N[Si](C)(C)C | 2590.3 | Standard polar | 33892256 | | Carisoprodol,1TMS,isomer #2 | CCCC(C)(COC(N)=O)COC(=O)N(C(C)C)[Si](C)(C)C | 1978.9 | Semi standard non polar | 33892256 | | Carisoprodol,1TMS,isomer #2 | CCCC(C)(COC(N)=O)COC(=O)N(C(C)C)[Si](C)(C)C | 1898.2 | Standard non polar | 33892256 | | Carisoprodol,1TMS,isomer #2 | CCCC(C)(COC(N)=O)COC(=O)N(C(C)C)[Si](C)(C)C | 2951.2 | Standard polar | 33892256 | | Carisoprodol,2TMS,isomer #1 | CCCC(C)(COC(=O)N[Si](C)(C)C)COC(=O)N(C(C)C)[Si](C)(C)C | 2056.0 | Semi standard non polar | 33892256 | | Carisoprodol,2TMS,isomer #1 | CCCC(C)(COC(=O)N[Si](C)(C)C)COC(=O)N(C(C)C)[Si](C)(C)C | 2040.5 | Standard non polar | 33892256 | | Carisoprodol,2TMS,isomer #1 | CCCC(C)(COC(=O)N[Si](C)(C)C)COC(=O)N(C(C)C)[Si](C)(C)C | 2337.0 | Standard polar | 33892256 | | Carisoprodol,2TMS,isomer #2 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N([Si](C)(C)C)[Si](C)(C)C | 2057.1 | Semi standard non polar | 33892256 | | Carisoprodol,2TMS,isomer #2 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N([Si](C)(C)C)[Si](C)(C)C | 2048.3 | Standard non polar | 33892256 | | Carisoprodol,2TMS,isomer #2 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N([Si](C)(C)C)[Si](C)(C)C | 2378.5 | Standard polar | 33892256 | | Carisoprodol,3TMS,isomer #1 | CCCC(C)(COC(=O)N(C(C)C)[Si](C)(C)C)COC(=O)N([Si](C)(C)C)[Si](C)(C)C | 2089.4 | Semi standard non polar | 33892256 | | Carisoprodol,3TMS,isomer #1 | CCCC(C)(COC(=O)N(C(C)C)[Si](C)(C)C)COC(=O)N([Si](C)(C)C)[Si](C)(C)C | 2148.2 | Standard non polar | 33892256 | | Carisoprodol,3TMS,isomer #1 | CCCC(C)(COC(=O)N(C(C)C)[Si](C)(C)C)COC(=O)N([Si](C)(C)C)[Si](C)(C)C | 2151.1 | Standard polar | 33892256 | | Carisoprodol,1TBDMS,isomer #1 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N[Si](C)(C)C(C)(C)C | 2205.6 | Semi standard non polar | 33892256 | | Carisoprodol,1TBDMS,isomer #1 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N[Si](C)(C)C(C)(C)C | 2124.0 | Standard non polar | 33892256 | | Carisoprodol,1TBDMS,isomer #1 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N[Si](C)(C)C(C)(C)C | 2623.7 | Standard polar | 33892256 | | Carisoprodol,1TBDMS,isomer #2 | CCCC(C)(COC(N)=O)COC(=O)N(C(C)C)[Si](C)(C)C(C)(C)C | 2225.9 | Semi standard non polar | 33892256 | | Carisoprodol,1TBDMS,isomer #2 | CCCC(C)(COC(N)=O)COC(=O)N(C(C)C)[Si](C)(C)C(C)(C)C | 2119.0 | Standard non polar | 33892256 | | Carisoprodol,1TBDMS,isomer #2 | CCCC(C)(COC(N)=O)COC(=O)N(C(C)C)[Si](C)(C)C(C)(C)C | 2955.3 | Standard polar | 33892256 | | Carisoprodol,2TBDMS,isomer #1 | CCCC(C)(COC(=O)N[Si](C)(C)C(C)(C)C)COC(=O)N(C(C)C)[Si](C)(C)C(C)(C)C | 2505.2 | Semi standard non polar | 33892256 | | Carisoprodol,2TBDMS,isomer #1 | CCCC(C)(COC(=O)N[Si](C)(C)C(C)(C)C)COC(=O)N(C(C)C)[Si](C)(C)C(C)(C)C | 2389.0 | Standard non polar | 33892256 | | Carisoprodol,2TBDMS,isomer #1 | CCCC(C)(COC(=O)N[Si](C)(C)C(C)(C)C)COC(=O)N(C(C)C)[Si](C)(C)C(C)(C)C | 2526.8 | Standard polar | 33892256 | | Carisoprodol,2TBDMS,isomer #2 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2514.5 | Semi standard non polar | 33892256 | | Carisoprodol,2TBDMS,isomer #2 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2410.0 | Standard non polar | 33892256 | | Carisoprodol,2TBDMS,isomer #2 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2530.4 | Standard polar | 33892256 | | Carisoprodol,3TBDMS,isomer #1 | CCCC(C)(COC(=O)N(C(C)C)[Si](C)(C)C(C)(C)C)COC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2758.1 | Semi standard non polar | 33892256 | | Carisoprodol,3TBDMS,isomer #1 | CCCC(C)(COC(=O)N(C(C)C)[Si](C)(C)C(C)(C)C)COC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2677.9 | Standard non polar | 33892256 | | Carisoprodol,3TBDMS,isomer #1 | CCCC(C)(COC(=O)N(C(C)C)[Si](C)(C)C(C)(C)C)COC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2484.9 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental GC-MS | GC-MS Spectrum - Carisoprodol EI-B (Non-derivatized) | splash10-0a4i-9200000000-7ee2bc67a583d40d99b8 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Carisoprodol EI-B (Non-derivatized) | splash10-0a4i-9200000000-7ee2bc67a583d40d99b8 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Carisoprodol GC-MS (Non-derivatized) - 70eV, Positive | splash10-052f-9320000000-ea5623d29b47a08ec316 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Carisoprodol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Carisoprodol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | MS | Mass Spectrum (Electron Ionization) | splash10-0a4l-9200000000-84ceb4ca447a62939b63 | 2014-09-20 | Not Available | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol LC-ESI-qTof , Positive-QTOF | splash10-056r-1920000000-df362ad4c912b7d0fb43 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol LC-ESI-QFT , positive-QTOF | splash10-004i-4910000000-0fe5eef3c39360c36d38 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol LC-ESI-QFT , positive-QTOF | splash10-01ot-9300000000-94d7b1adea0d831c0950 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol LC-ESI-QFT , positive-QTOF | splash10-03dj-9100000000-a99d65f53726ca3b6116 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol LC-ESI-QFT , positive-QTOF | splash10-03di-9000000000-618eb5a23da29ec51cb6 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol LC-ESI-QFT , positive-QTOF | splash10-03di-9000000000-d2d07fc2a5972fd4e9f8 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol LC-ESI-QFT , positive-QTOF | splash10-03di-9000000000-007521fa65c254bad2b6 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol , positive-QTOF | splash10-056r-1920000000-df362ad4c912b7d0fb43 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol 90V, Positive-QTOF | splash10-03di-9000000000-bf1fe057c44420039b3a | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol 15V, Positive-QTOF | splash10-004i-4910000000-e7f506802140a9e5d5f6 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol 45V, Positive-QTOF | splash10-03dj-9100000000-ab0f09b2ddbd1ef81090 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol 30V, Positive-QTOF | splash10-01ot-9300000000-1ebfa5d842a1f8d54673 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol 60V, Positive-QTOF | splash10-03di-9000000000-ef44fb81f70af0bfd465 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol 75V, Positive-QTOF | splash10-03di-9000000000-a7cb3ad99f7b8bfb6ed9 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carisoprodol 10V, Positive-QTOF | splash10-03di-6490000000-046fd220fa245140ddab | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carisoprodol 20V, Positive-QTOF | splash10-0a4i-9320000000-b08ca9d93b628ea8b4f3 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carisoprodol 40V, Positive-QTOF | splash10-052f-9100000000-4f09dfa1c188e3251a65 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carisoprodol 10V, Negative-QTOF | splash10-000x-9010000000-548142f811b5a3632f8d | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carisoprodol 20V, Negative-QTOF | splash10-0006-9000000000-37215ebd46867ac40f9f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carisoprodol 40V, Negative-QTOF | splash10-052f-9100000000-46650c3ec5dedc27b7ec | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carisoprodol 10V, Positive-QTOF | splash10-0lxt-7970000000-bf2aa9b29774479d4c05 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carisoprodol 20V, Positive-QTOF | splash10-0f6t-9410000000-9352c9b82fc7d1079dd7 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carisoprodol 40V, Positive-QTOF | splash10-03ec-9100000000-c1581d5627d6283a4fbf | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carisoprodol 10V, Negative-QTOF | splash10-0adi-2960000000-0132a40d2da121a22471 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carisoprodol 20V, Negative-QTOF | splash10-003r-3900000000-5ed690941e48fd4fa317 | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|